178 related articles for article (PubMed ID: 10553046)
1. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
[TBL] [Abstract][Full Text] [Related]
2. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.
Kweon MN; Fujihashi K; Wakatsuki Y; Koga T; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1999 Feb; 162(4):1904-9. PubMed ID: 9973457
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
[TBL] [Abstract][Full Text] [Related]
4. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
RodrÃguez-Pinto D; Moreno J
Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
[TBL] [Abstract][Full Text] [Related]
5. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
[TBL] [Abstract][Full Text] [Related]
6. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
7. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions.
Wu ZQ; Vos Q; Shen Y; Lees A; Wilson SR; Briles DE; Gause WC; Mond JJ; Snapper CM
J Immunol; 1999 Jul; 163(2):659-67. PubMed ID: 10395655
[TBL] [Abstract][Full Text] [Related]
8. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
Modlin CS; Todd GT; Cohen TD; Fairchild RL
Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
Jaiswal AI; Croft M
J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
[TBL] [Abstract][Full Text] [Related]
10. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
[TBL] [Abstract][Full Text] [Related]
11. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
Croft M; Joseph SB; Miner KT
J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
[TBL] [Abstract][Full Text] [Related]
12. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
Bourgeois C; Rocha B; Tanchot C
Science; 2002 Sep; 297(5589):2060-3. PubMed ID: 12242444
[TBL] [Abstract][Full Text] [Related]
13. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
Constant S; Schweitzer N; West J; Ranney P; Bottomly K
J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
[TBL] [Abstract][Full Text] [Related]
14. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
[TBL] [Abstract][Full Text] [Related]
15. Altered CD40 ligand induction in tolerant T lymphocytes.
Bowen F; Haluskey J; Quill H
Eur J Immunol; 1995 Oct; 25(10):2830-4. PubMed ID: 7589079
[TBL] [Abstract][Full Text] [Related]
16. Antigen specificity of dual reactive T hybridomas determines the requirement for CD40 ligand-CD40 interactions.
Ozaki ME; Karlsson L; Peterson PA; Webb SR
J Immunol; 1997 Jul; 159(1):214-21. PubMed ID: 9200457
[TBL] [Abstract][Full Text] [Related]
17. Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40.
Karupiah G; Sacks TE; Klinman DM; Fredrickson TN; Hartley JW; Chen JH; Morse HC
Virology; 1998 Jan; 240(1):12-26. PubMed ID: 9448685
[TBL] [Abstract][Full Text] [Related]
18. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.
Stout RD; Suttles J; Xu J; Grewal IS; Flavell RA
J Immunol; 1996 Jan; 156(1):8-11. PubMed ID: 8598498
[TBL] [Abstract][Full Text] [Related]
19. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
[TBL] [Abstract][Full Text] [Related]
20. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
Schrader CE; Stavnezer J; Kikutani H; Parker DC
J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]